Paraplatin, Gemzar Medicare Payments Increased For 2004; CMS Boosts Nine Drugs Effective April 1
This article was originally published in The Pink Sheet Daily
Executive Summary
Camptosar and Avonex will also receive higher reimbursements. Changes reflect data submitted by manufacturers under AWP "exceptions" process.